Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc (GSK) covers the period ending November 16, 2007. The report details a specific corporate action regarding the repurchase of the company's own shares in accordance with shareholder authority granted at the Annual General Meeting on May 23, 2007.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, cash flow, margins, debt, or liquidity metrics. The only financial data disclosed relates to the share repurchase transaction:
- Shares Purchased: 2,500,000 Ordinary shares of 25 pence each.
- Purchase Price: 1,195.5 pence per share.
- Treasury Holdings: Following the purchase, GSK holds 497,744,158 shares in Treasury.
- Treasury Percentage: Treasury shares represent 9.00% of total voting rights.
- Shares in Issue: 5,527,531,067 shares (excluding Treasury shares).
Material Changes
The material change reported is the reduction of outstanding shares due to the repurchase of 2,500,000 shares on November 16, 2007. This transaction increased the company's Treasury share count to 497,744,158 shares. The filing does not provide comparative data against prior periods for financial performance.
Guidance, Outlook, and Risks
The filing contains no guidance, outlook, management commentary on future performance, or discussion of risks and contingencies. It explicitly states that the announcement does not constitute an offer or solicitation to purchase securities and is made in conformity with the Financial Services Authority's Disclosure and Transparency Rules.
Key Facts for Investor Verification
- Verify the total number of shares in issue (5,527,531,067) for calculating ownership percentages under Disclosure and Transparency Rules.
- Confirm the Treasury share holding of 9.00% of total voting rights.
- Note that the repurchase price of 1,195.5 pence per share reflects the market price on November 16, 2007.
- Recognize that this filing is a notification of a specific transaction and does not contain quarterly or annual financial results.